AnaptysBio (ANAB) Competitor Comparison
We are evaluating the key criteria listed to compare AnaptysBio (ANAB) against its competitors in the Biotechnology industry.
Market Capitalization
153 / 368Gross Profits
222 / 278Total Revenue
169 / 300EBITDA
246 / 337Free Cashflow
238 / 352Quick Ratio
73 / 357Earnings per Share
317 / 359Dividend yield
0 / 6Total Cash
74 / 358Performance 3 years
181 / 368Performance 5 years
129 / 368Performance 10 years
104 / 368Linearity 3 years
115 / 368Linearity 5 years
21 / 368Linearity 10 years
17 / 367Total Rank
289 / 368Dividend Rank
23 / 368Valuation Rank
305 / 368Piotroski Rank
256 / 368Muliplier Rank
268 / 368Market Capitalization - ANAB ranking 153 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.